Innovotech reports year-on-year revenue increase for second-quarter 2009

Download PDF Copy

Aug 21 2009

NewsGuard 100/100 Score

Innovotech Inc. (TSX VENTURE:IOT) today announced its unaudited financial and operational results for the three and six month periods ended June 30, 2009.

Highlights:

- Company shows revenue increase over second quarter 2008.

- Positive clinical outcomes demonstrated for bioFILM PA

- Company maintains healthy cash reserve

"The Company has maintained its product development momentum through an increase in contract revenue in the second quarter and continuing strong cash reserves" say Dr. James Timourian, Chief Financial Officer of Innovotech. "bioFILM PA has achieved another milestone with the demonstration of positive clinical outcomes in use in cystic fibrosis patients (see www.innovotech.ca for more detail). Agress continues to show promise in an expanding portfolio of crop and disease uses while awaiting regulatory approval. Evaluation and licensing discussion have continued with several multinational agriculture companies."

http://www.innovotech.ca

Posted in:

Tags: Agriculture, Antibiotic, Cystic Fibrosis, Fibrosis, IoT

Comments (0)

Download PDF Copy

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.